يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Sean Ewings"', وقت الاستعلام: 0.76s تنقيح النتائج
  1. 1
    An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2

    المؤلفون: Michael Fisher, Megan Lawrence, Richard Fitzgerald, Saye Khoo, Laura Else, Andrew Owen, Keira Fines, Michael Jacobs, Thomas Jaki, Rebecca Crook, Christie Woods, Parys Hatchard, Kelly Byrne, Lauren Walker, Gareth Griffiths, Rajith K. R. Rajoli, Sean Ewings, Izabela Eberhart, Pavel Mozgunov, Rebecca Lyon, Colin Hale, Tom Fletcher, Helen Reynolds, Geoffrey Saunders, Henry Pertinez, Emmanuel Okenyi, Timothy Rowland, Lucy Johnson, Karen Martin, Alieu Amara, Sujan Dilly-Penchala, David G. Lalloo, Robert Waugh

    المساهمون: Fisher, Michael [0000-0003-2304-6434], Martin, Karen [0000-0002-6362-0501], Reynolds, Helen [0000-0001-7443-4520], Byrne, Kelly [0000-0001-8895-5618], Jaki, Thomas [0000-0002-1096-188X], Khoo, Saye [0000-0002-2769-0967], Owen, Andrew [0000-0002-9819-7651], Apollo - University of Cambridge Repository

    المصدر: Clinical Pharmacology and Therapeutics
    CLINICAL PHARMACOLOGY & THERAPEUTICS

    مصطلحات موضوعية: Adult, Male, qv_268.5, medicine.medical_specialty, Physiologically based pharmacokinetic modelling, Urine, Antiviral Agents, Article, Cmin, Young Adult, Pharmacokinetics, Internal medicine, wc_505, medicine, Humans, Pharmacology (medical), Adverse effect, wa_105, Pharmacology, business.industry, Research, Drug Repositioning, Nitazoxanide, Middle Aged, Nitro Compounds, Healthy Volunteers, COVID-19 Drug Treatment, Diarrhea, Thiazoles, Tolerability, qw_160, Female, medicine.symptom, business, medicine.drug

    وصف الملف: application/pdf; text/xml; text

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54180ab1be1e7ed86daeaf2ab703b5a0

    View record at Wiley
    أضف إلى المفضلة
  2. 2
    Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study

    المؤلفون: Kim Mallard, William Greenhalf, Lauren Walker, Susannah Condie, Ellice Marwood, Michael Jacobs, Tom Fletcher, Gareth Griffiths, Geoffrey Saunders, Sean Ewings, Victoria Shaw, Richard Fitzgerald, Kerensa Thorne, Olana Tansley-Hancock, Andrew Owen, Lucy Johnson, Sara Yeats, David G. Lalloo, Wendy Painter, Helen Reynolds, Henry Pertinez, Thomas Jaki, Christie Woods, Keira Fines, Emma Wrixon, Colin Hale, Andrea Corkhill, Katie Bullock, Mike Radford, Emily R. Adams, Nichola Downs, Saye Khoo, Justin Chiong, Wayne Holman, Rebecca Lyon, Pavel Mozgunov, Marcin D Bula, Jennifer L Gibney

    المصدر: The Journal of antimicrobial chemotherapy

    مصطلحات موضوعية: Microbiology (medical), Research design, Adult, qv_268.5, medicine.medical_specialty, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Article, law.invention, Randomized controlled trial, Pharmacokinetics, law, Internal medicine, Medicine, Humans, Pharmacology (medical), Symptom onset, Adverse effect, Pharmacology, business.industry, SARS-CoV-2, COVID-19, Bayes Theorem, w_20.5, Infectious Diseases, Clinical research, Treatment Outcome, Research Design, Toxicity, qw_160, business

    وصف الملف: text; application/vnd.openxmlformats-officedocument.wordprocessingml.document

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a5576a4da8769d3c6064bde32dbfec8
    https://eprints.soton.ac.uk/476394/

    أضف إلى المفضلة
  3. 3
    An open label, adaptive, phase 1 trial of high-dose oral nitazoxanide in healthy volunteers: an antiviral candidate for SARS-CoV-2

    المؤلفون: Robert Waugh, Rebecca Lyon, Timothy Rowland, Kelly Byrne, Rebecca Crook, Michael Fisher, Sean Ewings, Megan Lawrence, Sujan Dilly-Penchala, Henry Pertinez, Laura Else, Helen Reynolds, Thomas Jaki, Rajith K. R. Rajoli, Richard Fitzgerald, Andrew Owen, Pavel Mozgunov, Lauren Walker, Saye Khoo, Colin Hale, Parys Hatchard, Karen Martin, Keira Fines, Izabela Eberhart, Alieu Amara, Lucy Johnson, Gareth Griffiths, David G. Lalloo, Tom Fletcher, Geoffrey Saunders, Michael Jacobs, Christie Woods

    مصطلحات موضوعية: medicine.medical_specialty, Physiologically based pharmacokinetic modelling, business.industry, Bilirubin, Nitazoxanide, Urine, chemistry.chemical_compound, Cmin, chemistry, Pharmacokinetics, Tolerability, Internal medicine, Medicine, business, Adverse effect, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::45390ead44d97cf5e76f07e2c7b49732
    https://doi.org/10.1101/2021.09.10.21263376

    أضف إلى المفضلة
  4. 4
    Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a phase 1, dose-escalating, randomised controlled study

    المؤلفون: Kerensa Thorne, Andrew Owen, Justin Chiong, Thomas Jaki, Michael Jacobs, Gareth Griffiths, Sara Yeats, Tom Fletcher, Keira Fines, Susannah Condie, Geoffrey Saunders, Kim Mallard, Colin Hale, Jennifer L Gibney, Mike Radford, Nichola Downs, Olana Tansley-Hancock, Pavel Mozgunov, Marcin D Bula, Andrea Corkhill, Katie Bullock, Wendy Painter, Christie Woods, Victoria Shaw, William Greenhalf, Lauren Walker, David G. Lalloo, Wayne Holman, Richard Fitzgerald, Rebecca Lyon, Lucy Johnson, Henry Pertinez, Ellice Marwood, Sean Ewings, Emma Wrixon, Saye Khoo, Emily R. Adams, Helen Reynolds

    مصطلحات موضوعية: medicine.medical_specialty, Clinical research, Pharmacokinetics, Coronavirus disease 2019 (COVID-19), business.industry, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Internal medicine, Toxicity, Medicine, In patient, Adverse effect, business, Excess toxicity

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::d711f718d23a69bca351a8f58d141333
    https://doi.org/10.1101/2021.05.03.21256309

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء